{"disease":{"id":"pneumococcal-vaccines","name":"pneumococcal vaccines"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04664569","title":"National Bacterial Meningitis Study","phase":"","overall_status":"RECRUITING","enrollment_count":8230,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT05298800","title":"Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Centers for Disease Control and Prevention, China","has_results":false},{"nct_id":"NCT05721456","title":"Evaluation of the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil.","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":2400,"lead_sponsor_name":"Maria de Lourdes de Sousa Maia, MD","has_results":false},{"nct_id":"NCT03893448","title":"Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1720,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01953510","title":"Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT06151288","title":"Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":1015,"lead_sponsor_name":"Vaxcyte, Inc.","has_results":true},{"nct_id":"NCT05266456","title":"Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":835,"lead_sponsor_name":"Vaxcyte, Inc.","has_results":true},{"nct_id":"NCT05844423","title":"Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":802,"lead_sponsor_name":"Vaxcyte, Inc.","has_results":false},{"nct_id":"NCT06608199","title":"A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Beijing Minhai Biotechnology Co., Ltd","has_results":false},{"nct_id":"NCT06703203","title":"Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06077656","title":"Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Inventprise Inc.","has_results":true},{"nct_id":"NCT05297578","title":"Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Vaxcyte, Inc.","has_results":true},{"nct_id":"NCT05540028","title":"Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Inventprise Inc.","has_results":false},{"nct_id":"NCT06271681","title":"Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"VA Sierra Nevada Health Care System","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}